Premium
Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor
Author(s) -
Schmidt Stefan,
Irving Julie A. E.,
Minto Lynne,
Matheson Elizabeth,
Nicholson Lindsay,
Ploner Andreas,
Parson Walther,
Kofler Anita,
Amort Melanie,
Erdel Martin,
Hall Andy,
Kofler Reinhard
Publication year - 2006
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fj.06-6214fje
Subject(s) - glucocorticoid receptor , microbiology and biotechnology , biology , lymphoblast , glucocorticoid , polymerase chain reaction , loss of heterozygosity , southern blot , gene , genotype , apoptosis , genetics , cell culture , immunology , allele
Glucocorticoids (GCs) specifically induce apoptosis in malignant lymphoblasts and are thus pivotal in the treatment of acute lymphoblastic leukemia (ALL). However, GC‐resistance is a therapeutic problem with an unclear molecular mechanism. We generated ~70 GC‐resistant sublines from a GC‐sensitive B‐ and a T‐ALL cell line and investigated their mechanisms of resistance. In response to GCs, all GC‐resistant subclones analyzed by real‐time polymerase chain reaction (PCR) showed a deficient up‐regulation of the GC‐receptor (GR) and its downstream target, GC‐induced leucine zipper. This deficiency in GR up‐regulation was confirmed by Western blotting and on retroviral overexpression of GR in resistant subclones GC‐sensitivity was restored. All GC‐resistant subclones were screened for GR mutations using denaturing high‐pressure liquid chromatography (DHPLC), DNA‐fingerprinting, and fluorescence in situ hybridization (FISH). Among the identified mutations were some previously not associated with GC resistance: A484D, P515H, L756N, Y663H, L680P, and R714W. This approach revealed three genotypes, complete loss of functional GR in the mismatch repair deficient T‐ALL model, apparently normal GR genes in B‐ALLs, and heterozygosity in both. In the first genotype, deficiency in GR up‐regulation was fully explained by mutational events, in the second by a putative regulatory defect, and in the third by a combination thereof. In all instances, GC‐resistance occurred at the level of the GR in both models.—Schmidt, S., Irving, J. A. E., Minto, L., Matheson, E., Nicholson, L., Ploner, A., Parson, W., Kofler, A., Amort, M., Erdel, M., Hall, A., Kofler, R. Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor. FASEB J. 20, E2087–E2097 (2006)